CIM INVESTMENT MANAGEMENT INC Buys 3, Sells 2 in 4th Quarter

CIM INVESTMENT MANAGEMENT INC recently filed their 13F report for the fourth quarter of 2022, which ended on 2022-12-31.

The 13F report details which stocks were in a guru’s equity portfolio at the end of the quarter, though investors should note that these filings are limited in scope, containing only a snapshot of long positions in U.S.-listed stocks and American depository receipts as of the quarter’s end. They are not required to include international holdings, short positions or other types of investments. Still, even this limited filing can provide valuable information.

239 FOURTH AVENUE PITTSBURGH, PA 15222

As of the latest 13F report, the guru’s equity portfolio contained 248 stocks valued at a total of $254.00Mil. The top holdings were IVV(23.16%), IJH(5.50%), and IJR(4.03%).

According to GuruFocus data, these were CIM INVESTMENT MANAGEMENT INC’s top five trades of the quarter.

iShares Core U.S. Aggregate Bond ETF


The guru established a new position worth 82,145 shares in ARCA:AGG, giving the stock a 3.14% weight in the equity portfolio. Shares traded for an average price of $96.08 during the quarter.

On 02/18/2023, iShares Core U.S. Aggregate Bond ETF traded for a price of $98 per share and a market cap of $85.52Bil. The stock has returned -8.46% over the past year.

There is insufficient data to calculate the stock’s financial strength and profitability ratings.

iShares Core S&P 500 ETF


During the quarter, CIM INVESTMENT MANAGEMENT INC bought 7,175 shares of ARCA:IVV for a total holding of 153,185. The trade had a 1.08% impact on the equity portfolio. During the quarter, the stock traded for an average price of $384.6.

On 02/18/2023, iShares Core S&P 500 ETF traded for a price of $409.14 per share and a market cap of $307.55Bil. The stock has returned -5.33% over the past year.

There is insufficient data to calculate the stock’s financial strength and profitability ratings.

In terms of valuation, iShares Core S&P 500 ETF has a price-earnings ratio of 20.22 and a price-book ratio of 3.76.

Activision Blizzard Inc


The guru established a new position worth 19,303 shares in NAS:ATVI, giving the stock a 0.58% weight in the equity portfolio. Shares traded for an average price of $74.26000000000001 during the quarter.

On 02/18/2023, Activision Blizzard Inc traded for a price of $77.56999999999999 per share and a market cap of $60.71Bil. The stock has returned -3.62% over the past year.

GuruFocus gives the company a financial strength rating of 8 out of 10 and a profitability rating of 8 out of 10.

In terms of valuation, Activision Blizzard Inc has a price-earnings ratio of 40.40, a price-book ratio of 3.15, a price-earnings-to-growth (PEG) ratio of 404.00, a EV-to-Ebitda ratio of 24.08 and a price-sales ratio of 8.13.

The price-to-GF Value ratio is 1.00, earning the stock a GF Value rank of 6.

Twitter Inc


The guru sold out of their 20,229-share investment in NYSE:TWTR. Previously, the stock had a 0.39% weight in the equity portfolio. Shares traded for an average price of $50.72 during the quarter.

On 02/18/2023, Twitter Inc traded for a price of $53.7 per share and a market cap of $41.09Bil. The stock has returned -2.03% over the past year.

GuruFocus gives the company a financial strength rating of 5 out of 10 and a profitability rating of 4 out of 10.

In terms of valuation, Twitter Inc has a price-book ratio of 6.98, a EV-to-Ebitda ratio of 66.62 and a price-sales ratio of 8.22.

The price-to-GF Value ratio is 0.93, earning the stock a GF Value rank of 6.

Bristol-Myers Squibb Co


CIM INVESTMENT MANAGEMENT INC reduced their investment in NYSE:BMY by 9,985 shares. The trade had a 0.31% impact on the equity portfolio. During the quarter, the stock traded for an average price of $75.40000000000001.

On 02/18/2023, Bristol-Myers Squibb Co traded for a price of $71.11 per share and a market cap of $149.24Bil. The stock has returned 8.77% over the past year.

GuruFocus gives the company a financial strength rating of 6 out of 10 and a profitability rating of 8 out of 10.

In terms of valuation, Bristol-Myers Squibb Co has a price-earnings ratio of 24.11, a price-book ratio of 4.75, a price-earnings-to-growth (PEG) ratio of 1.28, a EV-to-Ebitda ratio of 9.37 and a price-sales ratio of 3.29.

The price-to-GF Value ratio is 0.94, earning the stock a GF Value rank of 6.


Please note, the numbers and facts quoted are as of the writing of this article and may not factor in the latest trading data or company announcements.

When GuruFocus covers insider information, we only track open market or the private purchase and sale of common stock with the transaction code of P or S. Therefore, all the transactions mentioned in this article are only the ones with transaction code of P or S.

Want to provide feedback on this article? Have questions or concerns? Get in touch with us here, or email us at [email protected]!

This article is general in nature and does not represent the opinions of GuruFocus or any of its affiliates. This article is not intended to be financial advice, nor does it constitute investment advice or recommendations. It was written without regard to your individual situation or financial goals. We aim to bring you fundamental, data-driven analysis, The information on this site is in no way guaranteed for completeness, accuracy or in any other way.